Posted: 11 August 2023 Prestige Biopharma, a biopharmaceutical company specializing in innovative antibody therapies, with a strong dedication to tackling pancreatic cancer, and Imagion Biosystems, the pioneer in molecular Magnetic Resonance Imaging (MRI) dedicated to changing the way we…
Posted: 11 August 2023 Atmo Biosciences, a company commercializing the world’s first ingestible gas-sensing capsule that provides insights into gut health and microbiome function, today announced it has commenced a pivotal clinical study to assess the use of…
Posted: 11 August 2023 Cartherics Pty Ltd built new laboratories in 2022/23 at Notting Hill Victoria just North of Monash University. The available area is a totally separate laboratory space of 155 m2 and 70 m2 open plan…
Posted: 11 August 2023 Merck travelled to the Northern Territory with the DeadlyScience team to pilot the first DeadlyLabs kit. It’s a project led by Indigenous Elders in the Robinson River region to share their knowledge, their ideas,…
Posted: 11 August 2023 Firebrick Pharma is pleased to announce that its Phase 3 trial of Nasodine Nasal Spray in the treatment for the common cold has successfully completed recruitment, with 500 subjects enrolled. “Subject to availability of…
Posted: 11 August 2023 INOVIQ Limited (ASX:IIQ) (INOVIQ or the Company), a developer of next-generation exosome solutions and precision diagnostics, today announced results from an equivalence study to evaluate exosome-based biomarkers and performance of the EXO-OC test algorithm…
Posted: 11 August 2023 Telix today announces that a first patient has been dosed in China in the pivotal Phase III registration study of TLX591-CDx (Illuccix®, Kit for the preparation of 68Ga-PSMA-11),[1] for the imaging of prostate cancer using positron…
Posted: 11 August 2023 Dimerix Limited (ASX: DXB) a biopharmaceutical company with late-stage clinical assets in inflammatory diseases, today confirmed that the independent Data Safety Monitoring Board (DSMB) has successfully concluded a second review of the ACTION3 phase…
Posted: 7 August 2023 Firebrick Pharma Limited (ASX:FRE) (Firebrick, Company) is pleased to announce that its Phase 2 trial of Nasodine® Nasal Spray (“Nasodine”) in COVID-19 achieved its primary endpoint. The primary endpoint was the reduction in viral…
Posted: 7 August 2023 Leading digital health company Adherium Limited (ASX:ADR) has signed a collaboration agreement with US–based Allergy Partners to transform asthma management for its more than 300,000 patients across 130 sites in 20 states. Allergy Partners…
Posted: 7 August 2023 AdAlta Limited (ASX:1AD), the clinical stage drug discovery company developing novel therapeutic products using its i-body platform provides an update on its lead fibrosis asset, AD-214. The first participants in the Company’s Phase I…
Posted: 7 August 2023 Mothers who eat apples and herbs in early pregnancy could be protecting the brain health of their children and grandchildren, a Monash University study using genetic models has found. The discovery is part of…